Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Reiko Matsuzawa"'
Autor:
Yutaka Fujiwara, Katsuhiro Masago, Reiko Matsuzawa, Teppei Yamaguchi, Naohiro Watanabe, Junichi Shimizu, Eiichi Sasaki, Yoshitsugu Horio
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 942-949 (2024)
Introduction: Patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) are at increased risk of central nervous system (CNS) metastasis at initial diagnosis and throughout treatment. In a phase 3 trial, lorlatinib,
Externí odkaz:
https://doaj.org/article/2aba73a40393419a80bec87fda815105
Autor:
Teppei Yamaguchi, Junichi Shimizu, Reiko Matsuzawa, Naohiro Watanabe, Yoshitsugu Horio, Yutaka Fujiwara
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Targeted therapy is now the standard of care in driver–oncogene-positive non-small cell lung cancer (NSCLC). Its initial clinical effects are remarkable. However, almost all patients experience treatment resistance to targeted t
Externí odkaz:
https://doaj.org/article/1c2193dbf8174ff9817695be22a0730a
Autor:
Yutaka Fujiwara, Kazuhiro Shimomura, Teppei Yamaguchi, Junichi Shimizu, Naohiro Watanabe, Reiko Matsuzawa, Kenta Murotani, Yoshitsugu Horio
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Interstitial lung disease (ILD) or pneumonitis caused by epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) or immune checkpoint inhibitors (ICI) is a major concern in the treatment of non-small cell lung cancer (NSCLC). Whether
Externí odkaz:
https://doaj.org/article/34ee6869c9004bd38ecb781f3c16fe80
Autor:
Reiko Matsuzawa, Masahiro Morise, Kentaro Ito, Osamu Hataji, Kosuke Takahashi, Junji Koyama, Yachiyo Kuwatsuka, Yasuhiro Goto, Kazuyoshi Imaizumi, Hidetoshi Itani, Teppei Yamaguchi, Yoshitaka Zenke, Masahide Oki, Makoto Ishii
Publikováno v:
EClinicalMedicine, Vol 66, Iss , Pp 102303- (2023)
Summary: Background: Immune checkpoint inhibitors (ICI) plus platinum-based chemotherapy has been recognized as a standard first-line therapy in non-small cell lung cancer (NSCLC); however, no prospective clinical trials of docetaxel (DTX) plus ramuc
Externí odkaz:
https://doaj.org/article/5bf2a2ed2cfa401eb7d3e4461978588a
Autor:
Kim Deoksu, Shunsaku Hayai, Junji Koyama, Reiko Matsuzawa, Keiko Wakahara, Ichidai Tanaka, Naozumi Hashimoto, Tetsunari Hase, Masahiro Morise, Yutaro Tamiya, Yoshie Shimoyama
Publikováno v:
Internal Medicine. 61:703-708
Amelanotic melanoma is a rare type of melanoma that shows little or no melanin pigmentation. When tumor lesions are not detected in cutaneous sites, the presence of melanin is the hallmark sign of malignant melanoma. We herein report a case of amelan
Autor:
Reiko Matsuzawa, Azusa Tanimoto, Kenzo Soejima, Katsuyuki Hotta, K. Kiura, Hiroyuki Yasuda, Eiki Ichihara, Seiji Yano, Ryo Takemura, Junko Hamamoto, Shinji Takeuchi, Hideki Terai, Junji Koyama, Takahiro Fukushima, Shinnosuke Ikemura, Mineyoshi Sato, Yoshitaka Zenke, Yuta Takashima, Shingo Matsumoto, Koichi Goto, Jun Sakakibara-Konishi, Masahiro Morise
Publikováno v:
Lung Cancer. 162:140-146
Objectives Several preclinical data proposed a potential efficacy of osimertinib, a third-generation EGFR tyrosine kinase inhibitor, for EGFR exon 20 insertion (EGFR ex20ins)-positive non-small cell lung cancer (NSCLC). However, reported case series
Autor:
Reiko, Matsuzawa, Masahiro, Morise, Fumie, Kinoshita, Ichidai, Tanaka, Junji, Koyama, Tomoki, Kimura, Yasuhiro, Kondoh, Taro, Tanaka, Koichiro, Shima, Tetsunari, Hase, Keiko, Wakahara, Makoto, Ishii, Naozumi, Hashimoto
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
We determined the clinical relevance of early C-reactive protein (CRP) and neutrophil-lymphocyte ratio (NLR) change in blood as surrogate markers of pro-tumor inflammation (PTI) for predicting clinical outcome of programmed cell death (PD)-1/programm
Autor:
Reiko Matsuzawa, Masahiro Morise, Fumie Kinoshita, Ichidai Tanaka, Junji Koyama, Tomoki Kimura, Yasuhiro Kondoh, Taro Tanaka, Koichiro Shima, Tetsunari Hase, Keiko Wakahara, Makoto Ishii, Naozumi Hashimoto
PurposeWe determined the clinical relevance of early C-reactive protein (CRP) and neutrophil-lymphocyte ratio (NLR) change in blood as surrogate markers of pro-tumor inflammation (PTI) for predicting clinical outcome of programmed cell death (PD)-1/p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd5b6b66f17ae00b70f63e1dbf9c7ea3
https://doi.org/10.21203/rs.3.rs-1846407/v1
https://doi.org/10.21203/rs.3.rs-1846407/v1
Autor:
Shotaro Okachi, Manami Sakurai, Toshinori Matsui, Takayasu Ito, Reiko Matsuzawa, Masahiro Morise, Keiko Wakahara, Makoto Ishii, Michitaka Fujiwara
Publikováno v:
Surgical Innovation. :155335062311602
Autor:
Reiko Matsuzawa, Shogo Nomura, Tomoyuki Naito, Hibiki Udagawa, Kakeru Hisakane, Kiyotaka Yoh, Seiji Niho, Shingo Matsumoto, Keisuke Kirita, Genichiro Ishii, Koichi Goto, Masayuki Ishibashi, Yuko Usui
Publikováno v:
Cancer Science
Cryoprobe is a novel transbronchial biopsy (TBB) tool that yields larger tissue samples than forceps. Pathological diagnosis and biomarker analysis, such as genetic alterations and programmed death‐ligand 1 (PD‐L1) expression, are paramount for p